Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acne Infection01:27

Acne Infection

91
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
91
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

119
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

654
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
654
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

719
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
719
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

156
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
156
The Skin Microbiota01:27

The Skin Microbiota

119
The human skin serves as a complex ecosystem inhabited by a diverse community of microorganisms, including bacteria, fungi, and viruses. This microbiome plays a critical role in maintaining skin health and defending against pathogenic invaders. The composition of microbial communities varies significantly across different regions of the body, influenced primarily by the local levels of moisture and sebum.Regional Variation in Skin MicrobiotaCutibacterium acnes predominantly colonizes sebaceous...
119

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials.

Dermatology and therapy·2026
Same author

Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.

Journal of drugs in dermatology : JDD·2026
Same author

High Curl Pattern Hair and Scalp Care Considerations to Mitigate Seborrheic Dermatitis.

Journal of cosmetic dermatology·2026
Same author

Classification of High Curl Pattern Hair: A Systematic Review and Clinical Perspective.

Journal of cosmetic dermatology·2026
Same author

Current and Future Management of Chronic Hand Eczema in Canada: Evolving Treatment Paradigms.

Journal of cutaneous medicine and surgery·2026
Same author

Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies.

Dermatology and therapy·2026

Related Experiment Video

Updated: Apr 27, 2026

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
03:10

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid

Published on: November 1, 2024

3.2K

A consensus on acne management focused on specific patient features.

Charles Lynde, Jerry Tan, Anneke Andriessen

    Journal of Cutaneous Medicine and Surgery
    |July 11, 2014
    PubMed
    Summary

    Acne treatment guidelines should consider individual patient features beyond clinical severity. A case-based approach incorporating patient-reported impact, gender, and skin type improves acne management and outcomes.

    More Related Videos

    Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
    09:32

    Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

    Published on: September 26, 2019

    6.6K
    Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
    04:12

    Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

    Published on: January 19, 2024

    2.1K

    Related Experiment Videos

    Last Updated: Apr 27, 2026

    Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
    03:10

    Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid

    Published on: November 1, 2024

    3.2K
    Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
    09:32

    Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

    Published on: September 26, 2019

    6.6K
    Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
    04:12

    Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

    Published on: January 19, 2024

    2.1K

    Area of Science:

    • Dermatology
    • Acne Pathogenesis
    • Treatment Strategies

    Background:

    • Current acne treatment guidelines primarily rely on clinical severity.
    • An individualized, case-based approach is proposed to enhance treatment selection.

    Observation:

    • An expert panel of Canadian dermatologists convened to identify key demographic and clinical features for acne treatment selection.
    • A nominal group consensus process was employed to define these features and associated treatments.

    Findings:

    • Follicular epithelial dysfunction is a key factor in acne pathogenesis.
    • Inflammation, whether from underlying conditions or prior treatments, influences subsequent management decisions.
    • Addressing patient-specific features and psychosocial factors, including quality of life, enhances treatment adherence and efficacy.
    • Case-based scenarios effectively illustrate the impact of these multifactorial considerations.

    Implications:

    • Acne management requires a multifactorial approach extending beyond clinical severity.
    • Patient-reported impact, gender, skin sensitivity, and phototype are crucial considerations for personalized acne care.
    • Integrating these factors into a case-based framework offers a practical method for optimizing acne treatment strategies.